OTCMKTS:SPHS Sophiris Bio - SPHS Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Sophiris Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket Capitalization$4,000.00P/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort Interest About Sophiris Bio (OTCMKTS:SPHS) StockSophiris Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products for the treatment of urological diseases. The company was founded by James L. Heppell in May 2003 and is headquartered in La Jolla, CA.Read More Receive SPHS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sophiris Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address SPHS Stock News HeadlinesMarch 20, 2023 | finance.yahoo.comSophiris Bio Inc. Registered Sh (BFF1.SG)January 25, 2023 | msn.comSPHS Indoor Track Wins Girls Blue Division at GMC ChampionshipsMarch 26, 2023 | Investor Place Media (Ad)Biden To Unleash "Choke Point" Operation On America?Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.January 17, 2023 | msn.comSPHS Weekly Sports Recap: All Sports Notch Big WinsOctober 24, 2020 | nasdaq.comSophiris Bio Inc (SPHS)August 19, 2020 | ca.finance.yahoo.comSophiris Bio, Inc. (SPHS)May 18, 2020 | finance.yahoo.comSophiris Bio To Shut Down OperationsApril 25, 2020 | www.barrons.comSophiris Bio Inc.March 26, 2023 | Weiss Ratings (Ad)Urgent WarningThis was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …March 10, 2020 | seekingalpha.comSophiris to delist; shares plummet 42% after hoursMarch 10, 2020 | finance.yahoo.comSophiris Bio Announces Nasdaq DelistingFebruary 22, 2020 | finance.yahoo.comSPHS Feb 2020 2.500 callNovember 18, 2019 | finance.yahoo.comSPHS: Single Phase 3 Clinical Trial Planned for Topsalysin in Localized Prostate Cancer…November 13, 2019 | seekingalpha.comSophiris Bio files for equity offeringNovember 7, 2019 | finance.yahoo.comSophiris Bio Reports Third Quarter 2019 Financial Results and Recent Corporate HighlightsOctober 21, 2019 | finance.yahoo.comSophiris Bio Receives Positive Feedback from FDA Regarding Phase 3 Localized Prostate Cancer Clinical Trial DesignAugust 30, 2019 | finance.yahoo.comSophiris Bio Announces Completion of $4.0 Million Registered Direct OfferingAugust 30, 2019 | finance.yahoo.comSophiris Bio to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceAugust 27, 2019 | finance.yahoo.comSPHS: Awaiting Feedback from FDA on Phase 3 Plan for Topsalysin in Prostate Cancer…August 27, 2019 | seekingalpha.comSophiris Bio secures $4M capital raiseAugust 9, 2019 | seekingalpha.comSophiris Bio EPS beats by $0.04June 20, 2019 | finance.yahoo.comSPHS: Details of Phase 3 Prostate Cancer Trial Based on Positive EMA Feedback…June 19, 2019 | finance.yahoo.comSophiris Bio Receives Positive Feedback from European Medicines Agency Regarding Phase 3 Localized Prostate Cancer Clinical Trial DesignJune 14, 2019 | finance.yahoo.comSome Sophiris Bio (FRA:BFF1) Shareholders Have Taken A Painful 79% Share Price DropMay 14, 2019 | finance.yahoo.comSPHS: EMA Guidance on Phase 3 Clinical Trial for Topsalysin Expected in 2Q19…May 9, 2019 | finance.yahoo.comSophiris Bio Reports First Quarter 2019 Financial ResultsApril 2, 2019 | finance.yahoo.comSophiris Bio to Present at Two Upcoming Investor ConferencesSee More Headlines Receive SPHS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sophiris Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address SPHS Company Calendar Last Earnings5/09/2019Today3/26/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceutical Preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:SPHS CUSIPN/A CIK1563855 Webwww.sophirisbio.com Phone(858) 777-1760FaxN/AEmployees2,018Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares35,550,000Free FloatN/AMarket Cap$4,000.00 OptionableNot Optionable Beta1.94 Key ExecutivesRandall E. WoodsPresident & Chief Executive OfficerPeter T. SloverChief Financial & Accounting OfficerKey CompetitorsAnthera PharmaceuticalsOTCMKTS:ANTHSkystar Bio-PharmaceuticalOTCMKTS:SKBIVerisante TechnologyOTCMKTS:VRSEFImmune TherapeuticsOTCMKTS:IMUNDGenocea BiosciencesNASDAQ:GNCAView All Competitors SPHS Stock - Frequently Asked Questions How were Sophiris Bio's earnings last quarter? Sophiris Bio, Inc. (OTCMKTS:SPHS) announced its quarterly earnings results on Thursday, May, 9th. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.02. What is Sophiris Bio's stock symbol? Sophiris Bio trades on the OTCMKTS under the ticker symbol "SPHS." How do I buy shares of Sophiris Bio? Shares of SPHS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. How much money does Sophiris Bio make? Sophiris Bio (OTCMKTS:SPHS) has a market capitalization of $0.00. How many employees does Sophiris Bio have? The company employs 2,018 workers across the globe. How can I contact Sophiris Bio? Sophiris Bio's mailing address is 1258 PROSPECT STREET, LA JOLLA CA, 92037. The official website for the company is www.sophirisbio.com. The company can be reached via phone at (858) 777-1760 or via email at cdavis@lifesciadvisors.com. This page (OTCMKTS:SPHS) was last updated on 3/26/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.